GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » Institutional Ownership

DOD Biotech PCL (BKK:DOD-R) Institutional Ownership : 0.12% (As of Jul. 24, 2025)


View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DOD Biotech PCL's institutional ownership is 0.12%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DOD Biotech PCL's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DOD Biotech PCL's Float Percentage Of Total Shares Outstanding is 0.00%.


DOD Biotech PCL Institutional Ownership Historical Data

The historical data trend for DOD Biotech PCL's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Institutional Ownership Chart

DOD Biotech PCL Historical Data

The historical data trend for DOD Biotech PCL can be seen below:

2019-09-30 2019-10-31 2019-11-30 2021-01-31 2021-02-28
Institutional Ownership 0.03 0.03 0.03 0.06 0.12

DOD Biotech PCL Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


DOD Biotech PCL Business Description

Traded in Other Exchanges
Address
No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines